Medical And Diagnostic Laboratory Services Global Market Report 2024

The medical and diagnostic laboratory services market size has grown strongly in recent years. It will grow from $189.45 billion in 2023 to $207.5 billion in 2024 at a compound annual growth rate (CAGR) of 9.5%. The growth observed during the historical period can be attributed to advancements in medical technology, the aging population, healthcare reform initiatives, the occurrence of epidemics and pandemics, as well as the prevalence of chronic diseases.

The medical and diagnostic laboratory services market size is expected to see strong growth in the next few years. It will grow to $275.39 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The anticipated growth in the forecast period can be attributed to factors such as precision medicine, the adoption of telemedicine and remote monitoring, personalized healthcare approaches, genomic testing, and regulatory changes. Key trends expected in the forecast period encompass point-of-care testing, the availability of home testing kits, the integration of artificial intelligence (AI) and data analytics, the emergence of telepathology and tele laboratory services, as well as a trend towards laboratory consolidation.

The global disease landscape is undergoing a transformation due to factors like the prevalence of sedentary jobs, busy lifestyles, and evolving consumer preferences. Non-communicable diseases such as cancer, diabetes, and cardiovascular diseases are becoming increasingly common, attributed to long working hours, reduced physical activity, and unhealthy dietary and drinking habits. Chronic diseases, including diabetes, are responsible for a significant portion of global deaths, with the World Health Organization reporting 41 million annual fatalities in 2021, constituting roughly 74% of all global deaths. Diagnostic tests such as HbA1c tests for diabetes monitoring, biopsies, tumor marker tests, bone scans, and advanced imaging techniques like MRI and CT scans for cancer diagnosis, as well as electrocardiograms, chest X-rays, cardiac CT scans, and stress tests for detecting cardiovascular diseases, are in high demand. As lifestyle-related diseases continue to rise, the demand for diagnostic tests to identify and manage these conditions is expected to drive the medical and diagnostic laboratory services market in the forecast period.

The principal categories within the realm of medical and diagnostic laboratory services consist of diagnostic imaging centers and medical laboratory services. A diagnostic imaging center serves as a provider offering specialized and comprehensive diagnostic imaging solutions. These services encompass both public and private sector expenditures and find applications in various medical fields such as cardiology, oncology, neurology, orthopedics, gastroenterology, gynecology, among others. These services cater to both male and female patients.

The medical and diagnostic laboratory services market research report is one of a series of new reports that provides medical and diagnostic laboratory services market statistics, including medical and diagnostic laboratory services industry global market size, regional shares, competitors with a medical and diagnostic laboratory services market share, detailed medical and diagnostic laboratory services market segments, market trends and opportunities, and any further data you may need to thrive in the medical and diagnostic laboratory services industry. This medical and diagnostic laboratory services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The growing elderly population is a significant driver of the medical and diagnostic laboratory services market. This demographic comprises older adults, typically aged 65 and above, and these individuals depend on medical and diagnostic laboratory services for early disease detection, monitoring, and timely interventions to improve their overall health. The World Health Organization predicts that globally, one in six individuals will be 60 or older by 2030, with an estimated 2.1 billion elderly people by 2050. This aging population is a driving force behind the growth of medical and diagnostic laboratory services.

The market for medical and diagnostic laboratory services may face limitations due to the increasing prevalence of self-care diagnostic equipment. These devices empower patients to independently diagnose specific disabilities or disorders, including glucose and blood pressure monitoring devices, sleep apnea monitors, and temperature monitors. The user-friendliness of self-care diagnostic tools has boosted their demand over the past decade and is expected to further increase in the forecast period. Additionally, virtual applications are aiding in the diagnosis of various health conditions, such as the development of the IOS accessory called Cue by iPhone for home diagnostics. This trend might negatively impact the traditional medical and diagnostic laboratory services market by reducing the necessity for laboratory testing in certain basic tests.

In the realm of medical and diagnostic laboratories, biomarkers are being employed to assess individual wellness and health parameters. These biomarkers, including cortisol, testosterone, and secretory IgA, can indicate changes in the immune system linked to physical and mental conditions, such as sleep disorders and stress symptoms. Physicians use these biomarkers to identify the underlying factors of these conditions, catering to individuals' well-being. This service is primarily oriented towards affluent individuals and senior corporate employees.

Prominent companies in the medical and diagnostic laboratory services market are focusing on innovative solutions, such as laboratory benefit management solutions, to maintain a competitive edge. Laboratory benefit management solutions are healthcare services designed to optimize and streamline laboratory testing utilization. For example, in June 2022, Optum Inc., a US-based healthcare company, introduced a laboratory benefit management solution aimed at helping health plans reduce unnecessary lab testing and ensure members receive appropriate, high-quality tests. This solution aligns testing with clinical evidence, enabling health plans to manage lab test utilization and spending more effectively, potentially saving health plans between $12 and $36 per member per year, totaling over $3 billion annually.

Major companies operating in the medical and diagnostic laboratory services market include Laboratory Corporation of America, Eurofins Scientific, Quest Diagnostics Incorporated, Sonic Healthcare Limited, Kaiser Permanente, RadNet, OPKO Health, Myriad Genetics, Charles River Laboratories Inc., NeoGenomics Laboratories Inc., Bio-Reference Laboratories Inc., Guardant Health Inc., Invitae Corporation, Natera Inc., Foundation Medicine Inc., Veracyte Inc., Exact Sciences Corporation, Fulgent Genetics Inc., Progenity Inc., Adaptive Biotechnologies Corporation, Guardion Health Sciences Inc., Biocept Inc., Interpace Biosciences Inc., Psychemedics Corporation, Aeon Global Health Corp., Avellino Labs USA Inc., Bio-Techne Corporation, Enzo Clinical Labs Inc., Genoptix Inc., Genova Diagnostics Inc.

North America was the largest region in the medical and diagnostic laboratory services market in 2023. Asia-Pacific was the second largest region in the medical and diagnostic laboratory services market. The regions covered in the medical and diagnostic laboratory services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the medical and diagnostic laboratory services market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa

The medical and diagnostic laboratory services market includes revenues earned by entities by providing diagnostic services such as diagnostic laboratory services, X-ray, CT scan, and Mammography. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.